Product NDC: | 0378-0873 |
Proprietary Name: | Clonidine |
Non Proprietary Name: | clonidine |
Active Ingredient(s): | .3 mg/d & nbsp; clonidine |
Administration Route(s): | TRANSDERMAL |
Dosage Form(s): | PATCH |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-0873 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076166 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130208 |
Package NDC: | 0378-0873-99 |
Package Description: | 4 POUCH in 1 CARTON (0378-0873-99) > 1 PATCH in 1 POUCH (0378-0873-16) > 7 d in 1 PATCH |
NDC Code | 0378-0873-99 |
Proprietary Name | Clonidine |
Package Description | 4 POUCH in 1 CARTON (0378-0873-99) > 1 PATCH in 1 POUCH (0378-0873-16) > 7 d in 1 PATCH |
Product NDC | 0378-0873 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clonidine |
Dosage Form Name | PATCH |
Route Name | TRANSDERMAL |
Start Marketing Date | 20130208 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | CLONIDINE |
Strength Number | .3 |
Strength Unit | mg/d |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |